Hinge Health/$HNGE

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Hinge Health

Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company's clients are self-insured employers.

Ticker

$HNGE
Sector

Primary listing

NYSE

Employees

1,514

Hinge Health Metrics

BasicAdvanced
$4B
-
-$19.47
-
-

What the Analysts think about Hinge Health

Analyst ratings (Buy, Hold, Sell) for Hinge Health stock.

Bulls say / Bears say

Hinge Health’s Q1 2025 revenue rose nearly 50% year-over-year to $123.8 million with a reported $17 million profit, marking a reversal of prior losses and demonstrating near-term profitability potential. (Reuters)
In Q2 2025, Hinge Health delivered 55% year-over-year revenue growth to $139 million and expanded its client base by 32% to 2,359 clients, underscoring strong adoption of its AI-powered MSK care platform. (CNBC)
Hinge Health’s guidance for Q3 2025 of $141–143 million in revenue exceeds analysts’ forecasts of $129 million, signaling management’s confidence in sustaining high growth rates. (CNBC)
Hinge Health reported a GAAP net loss of $575.65 million ($13.10 loss per share) in Q2 2025, highlighting continued significant unadjusted losses. (CNBC)
The company’s Q2 2025 GAAP loss from operations of $580.7 million included $591 million in stock-based compensation, raising concerns over dilution and underlying profitability. (CNBC)
Hinge Health’s IPO valuation target of up to $2.6 billion marked a steep discount from its $6.2 billion private valuation in 2021, reflecting investor skepticism about its long-term valuation. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 8 Sept 2025.

Hinge Health Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Hinge Health Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HNGE

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs